ALAXIA has a total of 11 patent applications. Its first patent ever was published in 2009. It filed its patents most often in France, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, medical technology and biotechnology are PHARMALINK AB, CATALENT ONTARIO LTD and PEROVITCH PHILIPPE.
# | Country | Total Patents | |
---|---|---|---|
#1 | France | 3 | |
#2 | EPO (European Patent Office) | 2 | |
#3 | WIPO (World Intellectual Property Organization) | 2 | |
#4 | Australia | 1 | |
#5 | Canada | 1 | |
#6 | New Zealand | 1 | |
#7 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Medical purpose containers | |
#4 | Fermentation |
# | Name | Total Patents |
---|---|---|
#1 | Bordeau Philippe | 11 |
#2 | Perraudin Jean-Paul | 5 |
#3 | Lenoir Barbara | 4 |
#4 | Collado Marc | 4 |
#5 | Martin Guillaume | 3 |
#6 | Perraudin Jean Paul | 1 |
#7 | Guillaume Martin | 1 |
#8 | Perrotto Sandrine | 1 |
#9 | Gluszok Sebastien | 1 |
Publication | Filing date | Title |
---|---|---|
EP2391330A1 | Device for the extemporaneous preparation of active preparations | |
FR2941374A1 | USE OF A SYNERGISTIC ASSOCIATION OF HYPOTHIOCYANITIS AND / OR HYPOHALITY IONS AND LACTOFERRIN FOR THE PREPARATION FOR THE TREATMENT OF MUCOVISCIDOSIS |